Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Circadian Rhythm | 10 | 2025 | 316 | 4.280 |
Why?
|
| Liver | 12 | 2025 | 1815 | 2.590 |
Why?
|
| Circadian Clocks | 5 | 2025 | 82 | 1.830 |
Why?
|
| Gene Expression Regulation | 7 | 2025 | 2446 | 1.220 |
Why?
|
| Lipid Metabolism | 5 | 2025 | 389 | 1.190 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 4 | 2023 | 23 | 1.150 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2025 | 293 | 0.980 |
Why?
|
| Quantitative Trait Loci | 1 | 2025 | 313 | 0.830 |
Why?
|
| Hepatocytes | 3 | 2023 | 241 | 0.820 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 2 | 2023 | 31 | 0.780 |
Why?
|
| Promoter Regions, Genetic | 1 | 2025 | 1294 | 0.720 |
Why?
|
| Genetic Variation | 2 | 2025 | 1583 | 0.660 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2021 | 121 | 0.650 |
Why?
|
| Professional Misconduct | 1 | 2019 | 35 | 0.630 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2019 | 73 | 0.590 |
Why?
|
| PPAR alpha | 1 | 2018 | 55 | 0.570 |
Why?
|
| Lipogenesis | 4 | 2023 | 60 | 0.510 |
Why?
|
| Feeding Behavior | 2 | 2020 | 728 | 0.460 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2025 | 3358 | 0.430 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2022 | 1412 | 0.380 |
Why?
|
| Mice, Inbred C57BL | 7 | 2025 | 4767 | 0.360 |
Why?
|
| Mice | 14 | 2025 | 18571 | 0.360 |
Why?
|
| Diet | 1 | 2018 | 1173 | 0.350 |
Why?
|
| Animals | 16 | 2025 | 34989 | 0.320 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2025 | 2851 | 0.270 |
Why?
|
| Obesity | 1 | 2018 | 2406 | 0.250 |
Why?
|
| Mice, Knockout | 3 | 2025 | 3873 | 0.250 |
Why?
|
| Hymecromone | 1 | 2025 | 10 | 0.240 |
Why?
|
| Drug Repositioning | 1 | 2025 | 31 | 0.240 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 2025 | 16 | 0.230 |
Why?
|
| Fungi | 1 | 2025 | 76 | 0.220 |
Why?
|
| Adipocytes | 3 | 2022 | 182 | 0.220 |
Why?
|
| Physical Conditioning, Animal | 1 | 2025 | 85 | 0.220 |
Why?
|
| Indoles | 1 | 2025 | 201 | 0.210 |
Why?
|
| Acetate-CoA Ligase | 1 | 2023 | 5 | 0.210 |
Why?
|
| Transcriptome | 3 | 2025 | 1125 | 0.210 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2025 | 326 | 0.190 |
Why?
|
| Receptors, Estrogen | 1 | 2025 | 741 | 0.180 |
Why?
|
| Peptides | 1 | 2025 | 847 | 0.180 |
Why?
|
| Thiazolidinediones | 1 | 2022 | 81 | 0.180 |
Why?
|
| Gene Expression | 2 | 2023 | 1564 | 0.170 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2021 | 13 | 0.170 |
Why?
|
| RNA, Small Untranslated | 1 | 2021 | 21 | 0.170 |
Why?
|
| Liver Cirrhosis | 2 | 2025 | 899 | 0.170 |
Why?
|
| Epigenomics | 1 | 2021 | 192 | 0.160 |
Why?
|
| Gene Deletion | 2 | 2020 | 795 | 0.160 |
Why?
|
| Hippocampus | 1 | 2025 | 819 | 0.160 |
Why?
|
| Cell Communication | 1 | 2020 | 187 | 0.160 |
Why?
|
| Kidney Diseases | 1 | 2023 | 488 | 0.150 |
Why?
|
| Fatty Liver | 2 | 2018 | 212 | 0.150 |
Why?
|
| Genotype | 1 | 2025 | 2706 | 0.150 |
Why?
|
| RNA | 1 | 2022 | 549 | 0.150 |
Why?
|
| Communication | 1 | 2023 | 540 | 0.150 |
Why?
|
| Glucocorticoids | 1 | 2021 | 386 | 0.150 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 406 | 0.140 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2017 | 17 | 0.140 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2023 | 422 | 0.140 |
Why?
|
| STAT2 Transcription Factor | 1 | 2017 | 3 | 0.140 |
Why?
|
| Light | 1 | 2018 | 184 | 0.140 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2017 | 11 | 0.140 |
Why?
|
| Promyelocytic Leukemia Protein | 1 | 2017 | 13 | 0.140 |
Why?
|
| Alzheimer Disease | 1 | 2025 | 865 | 0.130 |
Why?
|
| Humans | 13 | 2025 | 132334 | 0.130 |
Why?
|
| STAT1 Transcription Factor | 1 | 2017 | 76 | 0.130 |
Why?
|
| Genome | 1 | 2019 | 502 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 6 | 1 | 2016 | 2 | 0.130 |
Why?
|
| Insulin Resistance | 1 | 2022 | 703 | 0.130 |
Why?
|
| Male | 6 | 2025 | 65052 | 0.120 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 257 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2019 | 513 | 0.120 |
Why?
|
| Repressor Proteins | 1 | 2020 | 815 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2025 | 1829 | 0.120 |
Why?
|
| Interferon-alpha | 1 | 2017 | 246 | 0.120 |
Why?
|
| STAT3 Transcription Factor | 1 | 2017 | 232 | 0.110 |
Why?
|
| Hypoglycemic Agents | 1 | 2019 | 481 | 0.110 |
Why?
|
| Endothelium, Vascular | 1 | 2017 | 490 | 0.110 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 1997 | 0.110 |
Why?
|
| Stem Cells | 1 | 2019 | 732 | 0.100 |
Why?
|
| Actinin | 1 | 2012 | 7 | 0.100 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2012 | 46 | 0.100 |
Why?
|
| Neoplastic Stem Cells | 1 | 2015 | 348 | 0.090 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2012 | 161 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2018 | 917 | 0.090 |
Why?
|
| PPAR gamma | 2 | 2022 | 89 | 0.080 |
Why?
|
| Alternative Splicing | 1 | 2012 | 364 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2025 | 365 | 0.080 |
Why?
|
| Mice, Transgenic | 2 | 2025 | 2453 | 0.080 |
Why?
|
| Estrogen Receptor alpha | 1 | 2012 | 439 | 0.070 |
Why?
|
| Female | 2 | 2025 | 70786 | 0.070 |
Why?
|
| Protein Binding | 3 | 2019 | 1733 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 1426 | 0.070 |
Why?
|
| Protein Isoforms | 2 | 2022 | 422 | 0.060 |
Why?
|
| Gene Knockout Techniques | 2 | 2017 | 138 | 0.060 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2025 | 27 | 0.060 |
Why?
|
| Hyaluronic Acid | 1 | 2025 | 109 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 4695 | 0.050 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2025 | 133 | 0.050 |
Why?
|
| Kidney Tubules | 1 | 2023 | 75 | 0.050 |
Why?
|
| ErbB Receptors | 1 | 2025 | 295 | 0.050 |
Why?
|
| Cell Line | 2 | 2019 | 2730 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2025 | 3697 | 0.050 |
Why?
|
| Fibrosis | 1 | 2023 | 428 | 0.050 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2021 | 107 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2021 | 273 | 0.040 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2019 | 22 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 303 | 0.040 |
Why?
|
| NFI Transcription Factors | 1 | 2019 | 50 | 0.040 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2017 | 8 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2025 | 820 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2019 | 362 | 0.030 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2017 | 66 | 0.030 |
Why?
|
| Kidney | 1 | 2023 | 1331 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2017 | 101 | 0.030 |
Why?
|
| Endopeptidases | 1 | 2017 | 114 | 0.030 |
Why?
|
| Gene Editing | 1 | 2019 | 212 | 0.030 |
Why?
|
| Cholesterol | 1 | 2019 | 559 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 215 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 430 | 0.030 |
Why?
|
| RNA Interference | 1 | 2017 | 516 | 0.030 |
Why?
|
| Inflammation | 1 | 2023 | 1526 | 0.030 |
Why?
|
| Motor Activity | 1 | 2018 | 521 | 0.030 |
Why?
|
| Base Sequence | 1 | 2019 | 2904 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2018 | 1170 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 1357 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2018 | 804 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2025 | 4725 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2012 | 205 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 725 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 3062 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2015 | 688 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2015 | 816 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 759 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2017 | 1598 | 0.020 |
Why?
|
| Aged | 1 | 2019 | 21379 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 28888 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 31618 | 0.010 |
Why?
|